Report a side effect Contact Us
  • Who We Are
    Who We Are
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Overview
    • Vision, Mission & Values
    • Our History
    • Chairman Message
    • News and Media
      • Press Releases
      • Media Library
    • Sustainability & CSR
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.


    • Overview
    • Factory 1
    • Factory 2
    • Factory 3
    • Eiaco Factory
    • Eipico Plastic Factory
    • Industry Expansion
  • Science & Medicine
    Science & Medicine
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Products
    • Products (Alphabetical)
    • R&D and Quality
    • Global Accreditation
    • Regulatory Affairs
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Overview
    • Our Export History
    • Eipico Destination
  • Investor Relations
    Investor Relations
    • Investor Relations
    • Annual Reports
  • EIPICO 3
    EIPICO 3
    The First Modular Biological and Biosimilar Facility in Egypt
    • EIPICO 3 (Biologicals & Biosimilars)


Pharmacovigilance is the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

All medicines have risks as well as benefits. 

The aim of EIPICO.'s Pharmacovigilance Department is to enhance patient's health and safety in relation to the use of EIPICO.'s products through providing reliable, and balanced information to ensure that the overall benefits of medicines outweigh the risks.
Such aim is fulfilled by collecting Adverse Drug Reaction Reports/Customer Complaints and preparing Pharmacovigilance documents for each of EIPICO.'s marketed products routinely, to assess the medicines Benefit/Risk balance.
Thus, by reporting Adverse Drug Reactions/Complaints witnessed from a drug, we share in the continuous monitoring of the safety, efficacy and quality of the drug beside ensuring that the Benefit/Risk balance is updated in order to reach safer medicinal products and have a positive impact on the public safety/health. 

Report… Your Report Counts.

 

You may report any drug-related problem concerning EIPICO.'s medicinal products through: 

  • Email: Pharmacovigilance@eipico.net
  • Landline No.:  (+02) 24143660 - 24143550/Internal No.: 601 - 505 - 509 
  • Fax No.:  (+02) 24174528 - 24143800
For reporting drug-related Problems in the Kingdom of Saudi Arabia through
Egyptian International Pharmaceutical Industries Co. (EIPICO) 
Pharmacovigilance Department
 
Address: ‎2560 AlMallah, AlMurabba, Unit No. 1, Riyadh 12631-9104‎ 
Tel.: +966-11-4056428 # 121/115/116 
Fax: +966-11-4123969 
Email: icsrs.ksa@eipico.net  



Send us your complaint

* * * * * * * * * * * * *



WE ARE EIPICO

EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million, currently raised to EGP 1500 Million.

Quick Links

  • EIPICO 3
  • News
  • Products
  • Global accreditation
  • Global
  • Investor relations

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
     Visitors Count : 1331189